A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe
Condition: AIDS-related Kaposi's SarcomaInterventions: Drug: abacavir/3TC/zidovudine; Drug: abacavir /3TC plus ritonavir boosted lopinavirSponsors: Parirenyatwa Hospital; University of Colorado, Denver; GlaxoSmithKline; AbbottCompleted - verified October 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials